Trastuzumab 400 mg: A Targeted Treatment

Anniepery17 Jan, 2022Health

Introduced as a recombinant IgG1 monoclonal antibody, Trastuzumab 400 mg is focused on the treatment of individuals suffering from breast cancer and stomach cancer. The trastuzumab 440 mg is supplied in the form of an injection and should be given as an injection into your vein. It can also be given under the skin, usually over 60 minutes. Use an effective contraception method in order to prevent pregnancy during treatment with trastuzumab medicine and approximately for 7-months following the last dose of treatment. Respective patients should report to their health specialists in case they are pregnant, planning pregnancy, or breastfeeding. Connect to us at TOLL-FREE: 1800-889-1064 for procuring biosimilars of trastuzumab 440 mg, at the best reasonable cost.